Bexarotene Capsule, Liquid Filled
Product Images NDC 0591-2832

2 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 0591-2832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure diagram of bexarotene, showing its molecular arrangement with multiple carbon rings and functional groups, including a carboxyl group (COOH).*
FDA Label Image

1 (Image 2)

1 (Image 2)
Label for Bexarotene Capsules 75 mg, liquid-filled oral capsules. The label includes the NDC 0591-2832-01 and states the product is for prescription use only. It contains 100 capsules and is manufactured for Teva Pharmaceuticals USA, Inc. Storage instructions and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.